dc.contributor.author | Henjum, Sigrun | |
dc.contributor.author | Frøyland, Livar | |
dc.contributor.author | Haugen, Margaretha | |
dc.contributor.author | Holvik, Kristin | |
dc.contributor.author | Løvik, Martinus | |
dc.contributor.author | Skålhegg, Bjørn Steen | |
dc.contributor.author | Stea, Tonje Holte | |
dc.contributor.author | Strand, Tor A | |
dc.contributor.author | Iversen, Per Ole | |
dc.coverage.spatial | Norway | nb_NO |
dc.date.accessioned | 2018-05-04T11:13:29Z | |
dc.date.available | 2018-05-04T11:13:29Z | |
dc.date.created | 2017-10-13T13:16:27Z | |
dc.date.issued | 2017 | |
dc.identifier.isbn | 978-82-8259-268-0 | |
dc.identifier.uri | http://hdl.handle.net/11250/2497182 | |
dc.description.abstract | Short summary
At the request of the Norwegian Food Safety Authority, the Norwegian Scientific Committee for Food Safety (VKM) has characterised the risk of specified doses of L-aspartic acid in food supplements. VKM concludes that:
In adults (≥18 years), adolescents (14 to < 18 years) and children (10 to < 14 years), the specified doses 3000, 3500, 4000, 4500, 5000 and 5700 mg/day L-aspartic acid in food supplements may represent a risk of adverse health effects. | nb_NO |
dc.language.iso | eng | nb_NO |
dc.publisher | Norwegian Scientific Committee for Food Safety (VKM) | nb_NO |
dc.relation.ispartof | VKM Report | |
dc.relation.ispartofseries | VKM Report; | |
dc.relation.uri | https://vkm.no/risikovurderinger/allevurderinger/andrestoffer/laspartatikosttilskudd.4.761cd04215dabef8a9e830a4.html | |
dc.rights | Navngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/deed.no | * |
dc.subject | L-aspartic acid | nb_NO |
dc.subject | aspartate | nb_NO |
dc.subject | food supplement | nb_NO |
dc.subject | adverse health effect | nb_NO |
dc.subject | negative health effect | nb_NO |
dc.subject | Norwegian Food Safety Authority | nb_NO |
dc.subject | Norwegian Scientific Committee for Food Safety | nb_NO |
dc.subject | other substances | nb_NO |
dc.subject | risk assessment | nb_NO |
dc.subject | VKM | nb_NO |
dc.title | Risk assessment of "other substances" – L-aspartic acid. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safety | nb_NO |
dc.type | Research report | nb_NO |
dc.description.version | publishedVersion | nb_NO |
dc.source.pagenumber | 32 | nb_NO |
dc.source.issue | 11 | nb_NO |
dc.identifier.cristin | 1504456 | |
cristin.unitcode | 1991,0,0,0 | |
cristin.unitname | Sykehuset Innlandet HF | |
cristin.ispublished | true | |
cristin.fulltext | original | |